NASDAQ

Century Therapeutics, Inc. (IPSC)

♥ 1009 Thanks from members

Live price chart, market sentiment, and community perspectives for Century Therapeutics, Inc. (NASDAQ: IPSC).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Versant VenturesFounder: BlueRock TherapeuticsLeadership: Ivan Horak (Interim CEO and Chief Scientific Officer)Holder: Versant VenturesHolder: Bayer AGHolder: RA Capital ManagementiPSC-derived Cell TherapiesAllogeneic CAR-T and CAR-NK TherapiesImmune-Evasion Technologies#IPSC#Century Therapeutics#Biotech#Stem Cells#NASDAQ